259 related articles for article (PubMed ID: 21694775)
21. Increased visfatin expression is associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation.
Özcan E; Saygun NI; Ilıkçı R; Karslıoğlu Y; Muşabak U; Yeşillik S
Clin Oral Investig; 2017 May; 21(4):1113-1121. PubMed ID: 27283324
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses.
Kang L; Heng W; Yuan A; Baolin L; Fang H
Biochimie; 2010 Jul; 92(7):789-96. PubMed ID: 20188786
[TBL] [Abstract][Full Text] [Related]
23. Effect of NF-κB decoy on insulin resistance of adipocytes from patients with type 2 diabetes mellitus.
Zhong L; Luo Y; Huang C; Liu L
Diabetes Metab; 2011 Dec; 37(6):520-6. PubMed ID: 21664164
[TBL] [Abstract][Full Text] [Related]
24. The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes.
Kusminski CM; da Silva NF; Creely SJ; Fisher FM; Harte AL; Baker AR; Kumar S; McTernan PG
J Clin Endocrinol Metab; 2007 Jan; 92(1):270-6. PubMed ID: 17062773
[TBL] [Abstract][Full Text] [Related]
25. Role of peroxisome proliferator-activated receptor-gamma activation on visfatin, advanced glycation end products, and renal oxidative stress in obesity-induced type 2 diabetes mellitus.
Tabassum A; Mahboob T
Hum Exp Toxicol; 2018 Nov; 37(11):1187-1198. PubMed ID: 29441829
[TBL] [Abstract][Full Text] [Related]
26. Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease.
Pfützner A; Marx N; Walcher D; Löbig M; Seidel D; Forst T
Clin Lab; 2008; 54(7-8):237-41. PubMed ID: 18942491
[TBL] [Abstract][Full Text] [Related]
27. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes.
Kim KY; Kim JK; Jeon JH; Yoon SR; Choi I; Yang Y
Biochem Biophys Res Commun; 2005 Feb; 327(2):460-7. PubMed ID: 15629137
[TBL] [Abstract][Full Text] [Related]
28. NFκB as a potent regulator of inflammation in human adipose tissue, influenced by depot, adiposity, T2DM status, and TNFα.
Harte AL; Tripathi G; Piya MK; Barber TM; Clapham JC; Al-Daghri N; Al-Disi D; Kumsaiyai W; Saravanan P; Fowler AE; O'Hare JP; Kumar S; McTernan PG
Obesity (Silver Spring); 2013 Nov; 21(11):2322-30. PubMed ID: 23408599
[TBL] [Abstract][Full Text] [Related]
29. Effect of pioglitazone on visfatin expression in 3T3-L1 adipocytes and SD rats.
Lv Q; Wang Y; Wang W; Wang L; Zhou X
Endocr Res; 2009; 34(4):130-41. PubMed ID: 19878073
[TBL] [Abstract][Full Text] [Related]
30. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
Chang YC; Chang TJ; Lee WJ; Chuang LM
Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
[TBL] [Abstract][Full Text] [Related]
31. Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes.
Murakami K; Bujo H; Unoki H; Saito Y
Eur J Pharmacol; 2007 Apr; 561(1-3):206-13. PubMed ID: 17320860
[TBL] [Abstract][Full Text] [Related]
32. Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients.
Kang YS; Song HK; Lee MH; Ko GJ; Cha DR
Diabetes Res Clin Pract; 2010 Aug; 89(2):141-9. PubMed ID: 20409603
[TBL] [Abstract][Full Text] [Related]
33. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.
Tan BK; Chen J; Digby JE; Keay SD; Kennedy CR; Randeva HS
J Clin Endocrinol Metab; 2006 Dec; 91(12):5022-8. PubMed ID: 17003086
[TBL] [Abstract][Full Text] [Related]
34. Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus.
Kim HJ; Kim SK; Shim WS; Lee JH; Hur KY; Kang ES; Ahn CW; Lim SK; Lee HC; Cha BS
Diabetes Res Clin Pract; 2008 Jul; 81(1):42-9. PubMed ID: 18394743
[TBL] [Abstract][Full Text] [Related]
35. Visfatin is an adipokine, but it is not regulated by thiazolidinediones.
Hammarstedt A; Pihlajamäki J; Rotter Sopasakis V; Gogg S; Jansson PA; Laakso M; Smith U
J Clin Endocrinol Metab; 2006 Mar; 91(3):1181-4. PubMed ID: 16394088
[TBL] [Abstract][Full Text] [Related]
36. Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes.
Wanecq E; Prévot D; Carpéné C
J Physiol Biochem; 2009 Dec; 65(4):351-9. PubMed ID: 20358348
[TBL] [Abstract][Full Text] [Related]
37. Exogenous administration of visfatin affects cytokine secretion and increases oxidative stress in human malignant melanoma Me45 cells.
Buldak RJ; Polaniak R; Buldak L; Mielanczyk L; Kukla M; Skonieczna M; Dulawa-Buldak A; Matysiak N; Zwirska-Korczala K
J Physiol Pharmacol; 2013 Jun; 64(3):377-85. PubMed ID: 23959735
[TBL] [Abstract][Full Text] [Related]
38. Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity.
Romacho T; Azcutia V; Vázquez-Bella M; Matesanz N; Cercas E; Nevado J; Carraro R; Rodríguez-Mañas L; Sánchez-Ferrer CF; Peiró C
Diabetologia; 2009 Nov; 52(11):2455-2463. PubMed ID: 19727662
[TBL] [Abstract][Full Text] [Related]
39. Free fatty acids normalize a rosiglitazone-induced visfatin release.
Haider DG; Mittermayer F; Schaller G; Artwohl M; Baumgartner-Parzer SM; Prager G; Roden M; Wolzt M
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E885-90. PubMed ID: 16735449
[TBL] [Abstract][Full Text] [Related]
40. Glucagon-like peptide-1 upregulates visfatin expression in 3T3-L1 adipocytes.
Liu R; Ding X; Wang Y; Wang M; Peng Y
Horm Metab Res; 2013 Sep; 45(9):646-51. PubMed ID: 23670349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
